<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Advanced Biotherapy Inc. | Company News & Executive Profiles - ADVB | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/advanced+biotherapy+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Advanced Biotherapy Inc.]]></description>
	<s:counts start="0" returned="6" found="6" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Advanced Biotherapy Inc. Receives ``Notice of Allowance'' from Patent Office for Use of Antibodies to Treat Uveitis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Dec_1/ai_n7585456]]></link>
		<description><![CDATA[LOS ANGELES -- Company Expands Antibody Patent Portfolio for Treatment of Eye Disease and Plans to Develop Franchise for Treatment of Ocular Diseases  Advanced Biotherapy, Inc. (OTCBB:ADVB), dedicated to pioneering the development and use of therapeutic antibodies, announced that the Company has received a "Notice of Allowance" from the...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Dec 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/inflammation.html"><![CDATA[inflammation]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="tickers">ADVB</category>
	</item>
	<item>
		<title><![CDATA[Advanced Biotherapy Inc. Broadens Its Patent Estate]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_March_18/ai_98904286]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers  LOS ANGELES--BUSINESS WIRE--March 18, 2003  Advanced Biotherapy Inc. (OTCBB:ADVB) was notified by the United States Patent and Trademark Office USPTO that it has been issued U.S. Patent No. 6,534,059 for the use of antibody to gamma interferon to treat corneal transplant rejection. The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Mar 2003 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="tickers">ADVB</category>
	</item>
	<item>
		<title><![CDATA[Advanced Biotherapy Inc. Receives `Notice of Allowance' From United States Patent and Trademark Office for Use of Antibodies to Gamma Interferon to Treat Corneal Transplant Rejection]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Dec_2/ai_94785800]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  LOS ANGELES--BUSINESS WIRE--Dec. 2, 2002  Advanced Biotherapy Inc. (OTCBB:ADVB) has received a "Notice of Allowance" from the United States Patent and Trademark Office USPTO for a utility patent for the use of any form of antibody to gamma interferon to treat corneal transplant...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Dec 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/rejection.html"><![CDATA[rejection]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="tickers">ADVB</category>
	</item>
	<item>
		<title><![CDATA[Advanced Biotherapy, Inc. Discloses Use Patent for Antibodies to Interferon-Gamma in the Treatment of Five Autoimmune Diseases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_Dec_13/ai_80771104]]></link>
		<description><![CDATA[Business Editors, Health/Medical Writers  WOODLAND HILLS, Calif.--BW HealthWire--Dec. 13, 2001  Advanced Biotherapy, Inc. (OTCBB: ADVB) announced today that antibodies to interferon-gamma (IFN-g) are now protected under U.S. patent law for use in five diseases of autoimmune etiology. The announcement of the assignment of this patent number coincides with...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Dec 2001 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">ADVB,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Advanced Biotherapy Inc. Receives 'Notice of Allowance' for Antibody Utility Patent to Treat Autoimmune Diseases]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_August_20/ai_77315398]]></link>
		<description><![CDATA[Health/Medical Writers & Business Editors  LOS ANGELES--BW HealthWire--Aug. 20, 2001  Advanced Biotherapy Inc. (OTCBB:ADVB) has received a "notice of allowance" from the United States Patent and Trademark Office USPTO for a utility patent to be issued for an antibody to treat five autoimmune diseases.  The patent is...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 20 Aug 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/allowance.html"><![CDATA[allowance]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[patent]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+patent+and+trademark+office.html"><![CDATA[U.S. Patent and Trademark Office]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="tickers">ADVB</category>
	</item>
	<item>
		<title><![CDATA[Advanced Biotherapy Inc. Announces Filing of Form 10-QSB With The Securities and Exchange Commission]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_May_15/ai_74517093]]></link>
		<description><![CDATA[Business Editors  WOODLAND HILLS, Calif.--BUSINESS WIRE--May 15, 2001  Advanced Biotherapy Inc. (OTCBB:ADVB) today announced that the company electronically filed its form 10-QSB, for the quarter ended March 31, 2001, with the Securities and Exchange Commission.  The filing can be obtained electronically at http://www.edgar-online.com/brand/aol/glimpse/glimpse.pl?sym=ADVB.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 May 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advanced+biotherapy+inc..html"><![CDATA[Advanced Biotherapy Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADVB</category>
		<category domain="tickers">ADVB</category>
	</item>
</channel>
</rss>
